GlassScriptPhysician profile
Harold D Carlson
NPI 1023013315
$5,646.39
in general payments reported to CMS, 2019-2025
16 companies · $51.37 in 2025
The $51.37 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,607 · 2020: $2,742 · 2021: $220 · 2022: $26.86 · 2025: $51.37.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $51.37.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $51.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiovascular Systems INC. | $4,892.27 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $189.39 | 2019-2020 | |
| Boston Scientific Corporation | $176.91 | 2019-2021 | |
| Cook Medical LLC | $51.37 | 2025 | Hemospray |
| Abiomed | $47.93 | 2019 | |
| Amarin Pharma, INC. | $38.96 | 2020 | |
| Novartis Pharmaceuticals Corporation | $36.00 | 2019-2020 | |
| Saranas, INC. | $34.63 | 2021 | |
| Biotronik INC. | $27.62 | 2019 | |
| Getinge USA Sales, LLC | $27.45 | 2020 | |
| Impulse Dynamics (USA) INC. | $26.86 | 2022 | |
| Philips North America LLC | $23.68 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $20.76 | 2020 | |
| Nuwellis, INC. | $19.33 | 2020 | |
| Medtronic Vascular, INC. | $19.33 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.90 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harold Carlson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.